Jen Hanley

Mom of two amazing kids and wife, New Co in Bos, formerly KKR and Press Secretary to Senator/Candidate Hillary Clinton, Boston, NYC

[insurify @insurify]

Owning a car now costs Americans a record $5,851 a year for gas, insurance and maintenance. In Georgia, it’s $7,648.

@USATODAY's @Keith_Laing breaks down new Insurify data on the 10 most expensive states for car ownership: https://t.co/G1dbuJdShv

[insurify @insurify]

Insurify’s @JuliaTaliesin spoke with @washingtonpost reporters @merica and @rachelerman re: insurance costs shaping what voters care about.

Insurify is bringing the real impact of rising insurance costs into the national conversation.

https://t.co/sDQiYbOcJa

[Jen Hanley @Jenniferehanley]

@NickKristof @katiecouric @CNN @DanaBashCNN @jaketapper

[Jen Hanley @Jenniferehanley]

@EconomyBen Sara, I'm so sorry. He was such a tremendous talent as well as an incredibly kind and gracious person. He will always be greatly admired.

[Jen Hanley @Jenniferehanley]

I encourage everyone to read @AliceXinliZhang's insightful piece in @FortuneMagazine on the importance of conscious leadership. CEOs today must lead with empathy, embrace vulnerability, and foster transparency and trust. Read how this approach help drives success @VergeGenomics

[Alice Zhang @AliceXinliZhang]

Today, I write in @FortuneMagazine about how culture is the most overlooked aspect of building an AI company. Today's leaders don't pound their fists on the table and talk about how they're crushing it. They have the courage to simply be vulnerable. https://t.co/tOV8qAKB4k

[Verge Labs @Verge_Labs]

Biotech has long recognized the benefits of using digital endpoints in clinical trials. Putting it into practice has been another matter. Our CMO, Diego Cadavid, spoke to BioCentury Inc. about how Verge is paving the way with a digital-first approach in our proof-of-concept study for #ALS, including incorporating digital endpoints that measure mobility, speech and sleep. Read the article here: https://t.co/LWFckDAuRX

#digitalhealth #biotechnology #clinicaltrials

[Myeloid Therapeutics @MyeloidTx]

On #WorldCancerDay, we honor the millions of fighters, celebrate survivors, and remember the brave souls we've lost. @Myeloid, we remain committed to leveraging science and tech to help save lives. #CancerAwareness #InnovationAgainstCancer

[Myeloid Therapeutics @MyeloidTx]

As we embark on the next exciting phase of advancing our pipeline of programs, we are excited to welcome Robert Hofmeister Ph.D., as our Chief Scientific Officer. His expertise and stellar track record, will drive innovation and scientific excellence https://t.co/OthaF5QfCf

[Jen Hanley @Jenniferehanley]

Congratulations to the @MyeloidTx team! Their mRNA- based technology CREATE is a game-changer in the field of gene editing.
#MyeloidTherapeutics #GeneEditing #CRISPR #biotech

[Myeloid Therapeutics @MyeloidTx]

We're thrilled to share our CRISPR-Enabled Autonomous Transposable Element (CREATE), the first-of-its-kind RNA-based platform for programmable, large-scale gene editing. CREATE holds immense potential for patients. Dive deeper: https://t.co/ZaHXV65KCM
#Biotech #CRISPR #mRNA

[Jen Hanley @Jenniferehanley]

@fred_guttenberg Fred thank you for everything that you do so selflessly on behalf of America's children and families. Although I wish it was not necessary, you are an inspiration.

[Jen Hanley @Jenniferehanley]

@DougAndres Five weeks straight and Senators need a break? What is this preschool?

[Verge Labs @Verge_Labs]

We are proud that Verge's CMO Diego Cadavid, M.D. will be joined by colleagues to present data from our Phase 1 study of of VRG50635, a PIKfyve inhibitor for the potential treatment of ALS, during this week’s European Network to Cure ALS (ENCALS) 2023 meeting in Barcelona, Spain.

[Verge Labs @Verge_Labs]

At Next week’s ALS Gordon Research Conference in Switzerland, Irene Choi will share insights on PIKfyve, a potential therapeutic target for ALS discovered using Verge's all-in-human, AI-powered CONVERGE™ platform. Check out the full agenda here: https://t.co/hlTfwIc7TG

[Verge Labs @Verge_Labs]

Exciting news! We completed our Phase 1 #ClinicalTrial of VRG50635, a potential best-in-class small molecule inhibitor of PIKfyve for the treatment of ALS. We anticipate initiating a proof-of-concept study in ALS patients in Q4 2023. Learn more here https://t.co/q5U15b3ije

[Jen Hanley @Jenniferehanley]

@sarahsholder @sarahsholder great article about what is at stake here - you identify how this goes well beyond a woman's right to choose. This reporting is so important

[Valo Health @ValoHealth]

Our founder & CEO @DavidBerry26 joined other company leaders and entrepreneurs at the @NYSE to share his thoughts on leadership - See below!

[Jen Hanley @Jenniferehanley]

@JerryZremski @merrillcollege Congratulations Jerry! So well deserved.

[Jen Hanley @Jenniferehanley]

@jason_pontin 🙏

[Jen Hanley @Jenniferehanley]

@DesBieler Fact check for your editor Mikaela didn’t have a “stunning crash” during the GS race; as you pointed out in your story “she skied out again” in SL

[Jen Hanley @Jenniferehanley]

Some SPAC new re ⁦@ValoHealth⁩ and ⁦@khoslaventures⁩ Acquisition Co. Announcing Additional PIPE Commitments https://t.co/YJXk9uRyHi